| Kenneth E Allen, CRNA, MSA | |
|
10180 Se Sunnyside Rd, Clackamas, OR 97015-8970 | |
| (503) 652-2880 | |
| Not Available |
| Full Name | Kenneth E Allen |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 10180 Se Sunnyside Rd, Clackamas, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073627006 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | (Oregon) | Primary |
| Entity Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
Dementia care for south Asian people could be improved after researchers from The University of Manchester adapted a commonly used tool for judging perceptions of the disease.
The Fiscal Times: "There will be more at stake than just one drug's future when the Food and Drug Administration opens a two-day hearing Tuesday on the safety of the diabetes drug Avandia. The 30-member panel of outside experts will also be rendering judgment on research methods that are frequently used to compare effectiveness and are slated to become a pillar of the nation's drug safety monitoring system.
Nausea is one of the most debilitating symptoms of migraine and affects 80 percent of migraine suffers in the United States. Leading headache physician, Dr. Zoltan Medgyessy of the Berolina Clinic in Lohne, Germany demonstrated in a trial that pressure to the P6 antiemetic point on the inner wrist with an acupressure wristband is an effective and quick therapy for relieving nausea of migraine sufferers.
Studying drugs in pediatric populations is challenging because drugs often affect children differently than they do adults. The scarcity of pediatric studies limits the ability of doctors and scientists to predict drug dosing, safety and efficacy in children. To address this gap, the National Institutes of Health announced today 18 grants to help determine outcome measures and increase the likelihood of success of future trials of treatments for children.
The U.S. Food and Drug Administration announced on Oct. 27 that it has approved, for the first time, an oncolytic (cancer-killing) viral therapy in the United States. The drug was approved for use against late-stage melanoma, a deadly skin cancer that can be difficult to treat.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kenneth E Allen, CRNA, MSA 10180 Se Sunnyside Rd, Clackamas, OR 97015-8970 Ph: (503) 652-2880 | Kenneth E Allen, CRNA, MSA 10180 Se Sunnyside Rd, Clackamas, OR 97015-8970 Ph: (503) 652-2880 |
News Archive
Dementia care for south Asian people could be improved after researchers from The University of Manchester adapted a commonly used tool for judging perceptions of the disease.
The Fiscal Times: "There will be more at stake than just one drug's future when the Food and Drug Administration opens a two-day hearing Tuesday on the safety of the diabetes drug Avandia. The 30-member panel of outside experts will also be rendering judgment on research methods that are frequently used to compare effectiveness and are slated to become a pillar of the nation's drug safety monitoring system.
Nausea is one of the most debilitating symptoms of migraine and affects 80 percent of migraine suffers in the United States. Leading headache physician, Dr. Zoltan Medgyessy of the Berolina Clinic in Lohne, Germany demonstrated in a trial that pressure to the P6 antiemetic point on the inner wrist with an acupressure wristband is an effective and quick therapy for relieving nausea of migraine sufferers.
Studying drugs in pediatric populations is challenging because drugs often affect children differently than they do adults. The scarcity of pediatric studies limits the ability of doctors and scientists to predict drug dosing, safety and efficacy in children. To address this gap, the National Institutes of Health announced today 18 grants to help determine outcome measures and increase the likelihood of success of future trials of treatments for children.
The U.S. Food and Drug Administration announced on Oct. 27 that it has approved, for the first time, an oncolytic (cancer-killing) viral therapy in the United States. The drug was approved for use against late-stage melanoma, a deadly skin cancer that can be difficult to treat.
› Verified 9 days ago
Jessica Dawn Sexton-dorsett, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 10180 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-813-2000 | |
Natalie Christine Kramer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10180 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-652-2880 | |
Linda Newbloom, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 10180 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-652-2880 | |
Kyle Bowling, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 10180 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-813-2000 | |
Mrs. Heidi Egan, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10180 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-571-4698 | |
Mr. Craig G Kleiv, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10180 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-571-2617 |